Insider filing · CTMX
Sean A. McCarthy
CEO
profile →
CytomX Therapeutics, Inc.
CTMX · Healthcare · 7 filings in 24 months
ticker →
Sean A. McCarthy sold $462K of CytomX Therapeutics (CTMX)
Executed Nov 6 2025, disclosed Oct 16, 344 days later, against a two-business-day limit.
Value, as filed
$462K
101,793 sh × $4.54
Executed
Nov 6 2025
the trade date, as filed
Disclosed
Oct 16
344 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SMSean A. McCarthy (CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in CytomX Therapeutics, Inc. (CTMX). The largest single filing was $764K of CTMX (118,969 sh × $6.42, as filed), executed Mar 17.
The name
CTMXHealthcare · CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sean A. McCarthy in CTMX
CTMXSALE
CytomX Therapeutics, Inc.
$764K118,969 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET CTMXSALE CytomX Therapeutics, Inc. $462K
101,793 sh × $4.54
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET CTMXSALE CytomX Therapeutics, Inc. $149K
55,511 sh × $2.69
Exec Jun 16 2025
Filed Jun 17 2025 · 5:30 PM ET